Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Animal Proteins Ap

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT04923555Not ApplicableCompleted

Analysis of the Postprandial Effects of a Vegetable Protein Mixture Rich in Arginine, Cysteine and Leucine on Endothelial Dysfunction and Inflammation at Low Noise in Elderly People With Cardiometabolic Risk

NCT04731987Not ApplicableCompleted

Orange Juice, Hesperidin and Their Role in Vascular Health Benefit

Showing all 2 trials

Research Network

Common Treatments

  • Animal Proteins Ap1
  • Vegetable Proteins Vp Rich In Leucine Cystein Arginine1
  • No Protein T1
  • Beverage Consumption1

Active Sponsors

  • University Hospital, Clermont-Ferrand2
  • UMR 1019, Unité de Nutrition Humaine, INRAE, Auvergne-Rhône Alpes Center1
  • Department of Beverage Research, Chair of analysis and technology of plant-based foods, Geisenheim University1
  • European Fruit Juice Association (AIJN)1

Top Investigators

Related Conditions

  • Metabolic Syndrome2
  • Vascular Compliance1

Activity Timeline